Jesse GitakaEric OchomoVincent WereMark NanyingiEvelyn A OlangaWashingtone OchiengCollins OkoyoJohn VululeBernard Abong'oJ NjeruLucia KeterEric Ng'enoDorothy OlouchAllan ole KwallahDaniel Muthui KiboiEleanor A OchodoBernhards OgutuPaul M GichukiSammy M NjengaE AmukoyeL KamauElizabeth V. Mumbi KigonduAngella MakumiEdmund N NjagiShehu S AwanduJ MwaiEvans KomenJoseph M Ochieng' OduorBenard OchiengDavid OborEva A NambatiCaroline Buckee
P108
P1416
A Safety Study of Dapivirine Vaginal Ring in AfricaEmpiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionAn Extended Follow up of a RTS,S/AS01E Malaria Vaccine TrialControlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisDose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
P6153
P69
Q37837846-FB6B4151-D6D3-465C-B236-45492CFAC92AQ54802153-511D1FD0-684D-4722-A4E0-14AF445B014FQ55173004-12BCD67F-5B43-4FC1-AE9F-C00E39A3066AQ55174174-2F719013-EFA0-4354-A7A7-DD67E35E44DDQ55174174-E2475B27-BD1C-4367-B7EF-C86E7B351AA0Q55200996-9BCF182A-E223-45E5-90CD-270783FCE153Q55201023-1EB58F8E-00C3-46C2-BE7A-72D302CC080DQ55204295-8B56332D-D79A-479F-99B4-D41137A3A21DQ55207459-0E640751-7CF9-4F77-8A20-36D80067FB23Q55208632-729C9F5B-BE90-4C0D-AB97-64AF59E0F681Q55215029-9C241652-1C13-484A-8DBC-FC6B693B9586Q55215060-7507A60D-8FB6-4E3A-BDE0-2302E8285A4DQ55477617-6B9BBDFD-5DB2-4C0C-BA87-4336B536F567Q56148618-bc1204e8-46a7-6085-0823-e0a1013d2790Q56380501-4609E549-C935-4D11-BA7B-C3C190B976D1Q56481164-78AD1F57-B6F5-4107-9934-D66703A1B178Q58667920-3C992794-0852-4583-A628-31B77C74A2D7Q60044476-B79274E0-D3A7-444A-B8B5-E084199842CAQ63675695-A8DC3299-21AF-4ADC-B40E-2F00B1F67026Q64355484-20452245-745B-4004-90FC-AAF216A0468AQ71133027-E10EEC50-D988-47DF-A11B-6D915D6066CFQ71405575-114C843D-6CA4-4BDC-965E-1BF689180DDBQ71405575-6CE23312-3698-45FC-BF65-22066F78EE27Q84847163-B3D2E3AA-7141-4E52-BFDF-AA60AF2A7260Q86361549-47E78171-BBA9-4F24-A659-247B7E2A887CQ86361549-9AAC7C6B-E3BB-4787-8102-B4F2B5733B3EQ87117447-387EFD20-FB17-4214-B8AA-915959EDC7F8Q88111026-D4A6E5D9-BA50-4487-B9B4-20EAB48F37B7Q88155201-1AE52FF3-7A7B-4B8E-9E10-7EEEB287D538Q88443553-626D01AD-DA7E-4FA2-AEA0-06E2F1B65F24Q88926332-A5E27E24-9369-4984-9679-1940BAB33FFBQ89218281-8BC53B62-696F-4988-B274-8A868ACE68A8Q89218286-1DC48554-5CA8-4F7D-BE51-32C4A06AD288Q89800817-870A19CF-359B-47FC-B089-551BD5EF1FE7Q91546354-87362847-45b6-766a-15b8-17c616939e10
P108
description
kenianische Organisation
@de
organisatie uit Kenia
@nl
organizatë
@sq
state corporation and national health research organization in Kenya
@en
valtionyhtiö ja kansallinen terveyden tutkimusorganisaatio Keniassa
@fi
name
KEMRI
@sw
Kenian lääketieteellinen tutkimuslaitos
@fi
Kenya Medical Research Institute
@en
Kenya Medical Research Institute
@fr
type
label
KEMRI
@sw
Kenian lääketieteellinen tutkimuslaitos
@fi
Kenya Medical Research Institute
@en
Kenya Medical Research Institute
@fr
altLabel
KEMRI
@en
KEMRI
@fi
Kenya Medical Research Institute
@fi
Kenya Medical Research Institute
@sw
prefLabel
KEMRI
@sw
Kenian lääketieteellinen tutkimuslaitos
@fi
Kenya Medical Research Institute
@en
Kenya Medical Research Institute
@fr
P31
P214
P244
P6366
P646
P131
P17
P2002
kemri_kenya
P213
0000 0001 0155 5938
P214
P2397
UCnVJaZd5sCt_Zn_8oTMKgjw
P2427
grid.33058.3d
P244
P3417
Kenya-Medical-Research-Institute
P3500
P3608
KEP0510927938
P5008
P571
1979-01-01T00:00:00Z
P5785
P625
Point (36.803 -1.3139)